FilingSEC EDGARS-8
IRulya Therapeutics Files S-8 for Merger-Related Equity Incentive Plans
· SEC accepted
StagePost-merger integration
Filing content
The company filed an S-8 registration statement to register shares for its new equity incentive plan and to assume outstanding stock options from the merger.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…